COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,633 Articles (22,913 medRxiv, 8,720 bioRxiv)

Most recent first Previous |  Page 78: Articles 771-780  | Next

Polyfunctionality of broadly reactive non-neutralizing SARS-CoV-2 RBD antibodies
Rosenbaum, P., Planchais, C., Bruel, T., Beretta, M., Bolland, W., Staropoli, I., Guivel-Benhassine, F., Schwartz, O., Mouquet, H.
10.1101/2025.08.26.672080 — Posted: 2025-08-26
The 2'-endo conformation of arabinose-CTP and arabinose-UTP inhibit viral polymerases by inducing long pauses.
Xiao, Z., Das, A., Jain, A., Anderson, T. K., Cameron, C. E., Arnold, J. J., Dulin, D., Kirchdoerfer, R. N.
10.1101/2025.08.26.672356 — Posted: 2025-08-26
Post-COVID-19 Epidemiological Insights and SEIR Modeling for Future Global Pandemic Preparedness: Lessons from the Western Pacific
Chinprateep, A.
10.1101/2025.08.12.25333519 — Posted: 2025-08-25
SARS-CoV-2 NSP14 inhibitor exhibits potent antiviral activity and reverses NSP14-driven host modulation
Luo, M., Mo, J., Wang, Z., Wei, H., Chen, K., Shen, L., Wang, Y., Li, L., Chen, Y., Chen, W., Li, X., Feng, H., Wang, X., Zhou, H., Xu, F., Zhao, Q., Xu, Y., Che, J., Zou, P., Zhang, R., Dong, X., Xie, W.
10.1101/2025.08.21.671674 — Posted: 2025-08-25
Nationwide estimates of SARS-CoV-2 infection fatality rates and numbers needed to vaccinate for SARS-CoV-2 vaccines in 2024 in Austria
Riedmann, U., Sprenger, M., Ioannidis, J., Pilz, S.
10.1101/2025.08.20.25334029 — Posted: 2025-08-24
Safety and immunogenicity of a single dose of a JN.1 variant COVID-19 vaccine in previously vaccinated adults: Primary analysis report of a phase 3 open-label trial
Alves, K., Kouassi, A., Nelson, J., Plested, J. S., Kalkeri, R., Zhu, M., Cloney-Clark, S., Cai, Z., Ahmed, A., McKnight, I., Mallory, R. M., Noriega, F.
10.1101/2025.08.20.25334074 — Posted: 2025-08-24
Seasonality and Trends in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Before and During the COVID-19 Pandemic: A 10-Year Pharmacovigilance Study
Mukherjee, E. M., Park, D. J., Krantz, M. S., Stone, C. A., Martin-Pozo, M., Phillips, E. J.
10.1101/2025.08.20.25331677 — Posted: 2025-08-24
Beyond the freedom to refuse patient: a retrospective comparative study of emergency transportation during the COVID-19 pandemic in Japan
Hirata, K., Chiba, T., Takaku, R., Meilai, C., Ikeda, S., Shiga, T.
10.1101/2025.08.19.25334036 — Posted: 2025-08-24
Integrative Modeling of SARS-CoV-2 Infection Dynamics to Inform COVID-19 Vaccination Strategies
Waema, R., Kaumbutha, C. M., Orwa, T.
10.1101/2025.08.19.25333964 — Posted: 2025-08-24
Factors associated with severe COVID-19 outcomes among adults with at least a primary vaccination schedule: a retrospective cohort study from Alberta, Canada
Aponte-Hao, S., Luu, H., Martins, K. J. B., Randall, J. R., Saxinger, L., Rennert-May, E., Leal, J., Williamson, T., Wilson, A., Blake, M., Lu, T., Iqbal, S. M., Mansi, J. A., Araujo, A. B., Martin, D., Klarenbach, S. W.
10.1101/2025.08.19.25334000 — Posted: 2025-08-24

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).